Skip to main content
SpringerLink
Log in
Book cover

Angiotensin und Herz pp 1–15Cite as

Lokale Expression und pathophysiologische Rolle von Renin-Angiotensin im Gefäßsystem und im Herzen

  • Chapter

  • 16 Accesses

Zusammenfassung

Während das zirkulierende Renin-Angiotensin-System (RAS) bei der kurzfristigen Aufrechterhaltung der kardiovaskulären Homöostase eine wichtige Rolle spielt, weisen neueste Studien darauf hin, daß das endogene RAS in Zielgeweben eine Rolle bei der langfristigen kardiovaskulären Regulation spielt. Dieser Artikel konzentriert sich auf die verschiedenen Wirkungen des Angiotensin Converting Enzyme (ACE) im Gewebe und von Angiotensin II (Ang II), seinem aktiven Peptidprodukt. Von Angiotensin II wurde nachgewiesen, daß es in glatten Gefäßmuskelzellen ein potenter Wachstumsfaktor ist. Je nach den lokalen Gegebenheiten kann die vaskuläre Reaktion eine Hypertrophie oder eine Hyperplasie sein. Die molekularen Mechanismen, die bei den Interaktionen von Angiotensin II mit Zellprodukten aus Endothel- oder glatten Muskelzellen beteiligt sind, können bei der Modulation der Gefäßstruktur bei der Hypertonie und bei einer Gefäßschädigung eine wichtige Rolle spielen. Auch gibt es Hinweise dafür, daß Angiotensin II bei der Entwicklung einer linksventrikulären Hypertrophie beim Hochdruck eine Rolle spielt. Darüber hinaus kann das kardiale RAS zur Pathophysiologie der Herzinsuffizienz beitragen. Experimentelle und klinische Studien mit ACE-Hemmern deuten darauf hin, daß die ACE-Aktivität im Gewebe bei der Entwicklung der Atherosklerose, bei der kardialen Hypertrophie und beim kardialen Umbau von Bedeutung ist.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aberg G, Ferrer P(1990) Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 15 (suppl 5 ): 65–72

    Google Scholar 

  2. Admiraal PJJ, Derkx FHM, Jan Danser AH, Pieterman H, Schalenkamp MADH (1990) Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.. Hypertension 15: 44–55

    Google Scholar 

  3. Alhenc-Gelas F, Soubrier F, Hubert C, Allegrini J, Corvol P (1989) The peculiar characteristics of the amino acid sequence of angiotensin I-converting enzyme, as determined by cDNA cloning of the human endothelial enzyme. J Cardiovasc Pharmacol 14 (suppl 4): 6–9

    Article  Google Scholar 

  4. Alhenc-Gelas F, Soubrier F, Hubert C, Allegrini J, Lattion AL, Corvol P (1990) The angiotensin I-converting enzyme (kininase II): progress in molecular and genetic structure. J Cardiovasc Pharmacol 15 (suppl 6): 25–29

    Google Scholar 

  5. Becker RHA, Weimer G, Linz W (1991) Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol 18 (suppl 2): S110 — S115

    PubMed  CAS  Google Scholar 

  6. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveller D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644

    Article  PubMed  CAS  Google Scholar 

  7. Campbell DJ (1985) The site of angiotensin production. J Hypertension 3: 730–737

    Article  Google Scholar 

  8. Campbell DJ (1987) Circulating and tissue angiotensin systems. J Clin Invest 79: 1–6

    Article  PubMed  CAS  Google Scholar 

  9. Carretero OA, Miyazaki S, Scicli AG (1981) Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril. Hypertension 3: 18–22

    Article  PubMed  CAS  Google Scholar 

  10. Chevillard C, Brown NL, Jouquey S, Mathiou M-N, Laliberte F, Gamon G (1989) Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats. J Cardiovasc Pharmacol 14: 297–301

    Article  PubMed  CAS  Google Scholar 

  11. Chobanian AV (1990) The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis. Clin Cardiol 13:VII-43—VII-48

    Google Scholar 

  12. Chobanian AV, Haudenschild CC, Nickerson C, Drago R (1990) Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15: 327–331

    Article  PubMed  CAS  Google Scholar 

  13. Crawford DC, Chobanian AV, Brecher P (1992) Angiotensin II increases fibronectin expression in rat cardiac fibroblasts in vivo (Abstr). Circulation 86 (suppl I): I - 89

    Google Scholar 

  14. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450–456

    Google Scholar 

  15. Dahlöf B, Pennert K, Hansson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertension 5: 95–110

    Google Scholar 

  16. Drexler H, Lindpaintner K, Lu W, Schieffer B, Ganten D (1989) Transient increase in the expression of cardiac angiotensinogen in a rat model of myocardial infarction and failure (Abstr). Circulation 80 (suppl II): II - 459

    Article  Google Scholar 

  17. Dzau V (1987) Vascular angiotensin pathways: new therapeutic target. J Cardiovasc Pharmacol 10 (suppl 7): 9–16

    Article  Google Scholar 

  18. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH (1981) Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63: 645–651

    Article  PubMed  CAS  Google Scholar 

  19. Dzau VJ, Ellison KE, Brody T, Ingelfinger J, Pratt RE (1987) A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology 120: 2334–2338

    Article  PubMed  CAS  Google Scholar 

  20. Dzau VJ, Gibbons GH (1987) Autocrine-paracrine mechanisms of vascular myocytes in hypertension. Am J Cardiol 60: 991–1031

    Google Scholar 

  21. Dzau VJ, Gibbons GH, Pratt RE (1991) Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18 (suppl 1I):II-100—II-105

    Google Scholar 

  22. Dzau VJ, Pratt RE (1986) Renin-angiotensin system: biology, physiology and pharmacology. In: Haber E, Morgan H, Katz A, Fozzard H (eds) Handbook of experimental cardiology; Raven Press, New York, pp 1631–1661

    Google Scholar 

  23. Dzau VJ, Re RN (1987) Evidence for the existence of renin in the heart. Circulation 73 (suppl I): 1134–1136

    Google Scholar 

  24. Eichstaedt H, Danne O, Langer M, Cordes M, Schubert C, Felix R, Schmutzler H (1989) Regression of left ventricular hypertrophy under ramipril treatment investigated by nuclear magnetic resonance imaging. J Cardiovasc Pharmacol 13 (suppl 3): 75–80

    Article  Google Scholar 

  25. Fabris B, Jackson B, Kohzuki M, Perich R, Johnston CI (1990) Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure. Clin Exp Pharmacol Physiol 17: 309–314

    Article  PubMed  CAS  Google Scholar 

  26. Farhy RD, Ho KL, Carretero OA, Scicli AG (1992) Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem and Biophys Res Comm 182: 283–288

    Article  CAS  Google Scholar 

  27. Folkow B (1990) “Structural factor” in primary and secondary hypertension. Hypertension 16:89–101

    Google Scholar 

  28. Ganten D, Hutchinson JS, Haebara H, Schelling P, Fischer H, Ganten U (1976) Tissue iso-renins. Clin Sci Mol Med 51: 117–120

    Google Scholar 

  29. Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Frohlich ED (1988) Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension. Am J Cardiol 62: 912–916

    Article  PubMed  CAS  Google Scholar 

  30. Geisterfer AAT, Peach MJ, Owens GK (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749–756

    Article  PubMed  CAS  Google Scholar 

  31. Gibbons GH, Pratt RE, Dzau VJ (1989) Angiotensin is a bifunctional modulator of vascular smooth muscle cell growth: Interaction with basic fibroblast growth factor (abstract). Hypertension 14: 358

    Google Scholar 

  32. Gibbons GH, Pratt RE, Dzau VJ (1992) Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-131 expression determines growth response to angiotensin II. J Clin Invest 90: 456–461

    Article  PubMed  CAS  Google Scholar 

  33. Gibbons GH, Pratt RE, Dzau VJ (1992) Role of autocrine transforming growth factor-ß1 expression and activation in determining vascular myocyte growth response to angiotensin II versus basic fibroblast growth factor ( Abstr ). Clin Res 39: 287A

    Google Scholar 

  34. Griendling KK, Berk BC, Ganz P, Gimbrone MA, Alexander RW (1987) Angiotensin II stimulation of vascular smooth muscle phosphoinositide metabolism: state of the art lecture. Hypertension 9 (suppl 3):III-181—III-185

    Google Scholar 

  35. Hermans WR, Rensing BJ, Foley DP, Deckers JW, Rutsch W, Enamuelsson H, Danchin N, Wijns W, Chappuis F, Serruys PW (1992) Therapeutic dissection after successful coronary balloon angioplasty: No influence on restenosis or on clinical outcome in 693 patients. J Am Coll Cardiol 20: 767–780

    Article  PubMed  CAS  Google Scholar 

  36. Hilgers KF, Kuczera M, Wilhem MJ, Wiecek A, Ritz E, Ganten D, Mann JFE (1989) Angiotensin formation in the isolated rat hindlimb. J Hypertension 7: 789–798

    Article  CAS  Google Scholar 

  37. Hirsch AT, Dzau VJ (1990) Tissue renin-angiotensin systems in the pathophysiology of heart failure. In: Brachmann J, Dietz R, Kübler W (eds) Heart failure and arrhythmias; Springer-Verlag, Heidelberg

    Google Scholar 

  38. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ (1991) Tissue-specific activation of cardiac angiotensin-converting enzyme in experimental heart failure. Circ Res 69: 475–482

    Article  PubMed  CAS  Google Scholar 

  39. Hirsch AT, Talsness CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ (1992) Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation 86: 1566–1574

    Article  PubMed  CAS  Google Scholar 

  40. Ichikawa I, Brenner BM (1984) Glomerular actions of angiotensin II. Am J Med 76: 43–49

    Article  PubMed  CAS  Google Scholar 

  41. Itoh H, Pratt RE, Dzau VJ (1990) Atrial natriuretic factor inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86: 1690–1697

    Article  PubMed  CAS  Google Scholar 

  42. Jackson B, Mendelsohn FA, Johnston CI (1991) Angiotensin-converting enzyme inhibition: prospects for the future. J Cardiovasc Pharmacol 18 (suppl 7): 4–8

    Article  Google Scholar 

  43. Jayakody L, Kappagoda T, Senaratne MPJ, Thomson ABR (1988) Impairment of endothelium-dependent relaxation: an early marker for atherosclerosis in the rabbit. Br J Pharmacol 94: 335–346

    Article  PubMed  CAS  Google Scholar 

  44. Katoh Y, Komuro I, Shibasaki Y, Yamaguchi H, Yazaki Y (1989) Angiotensin II induces hypertrophy and oncogene expression in cultured rat heart myocytes (Abstr). Circulation 80 (suppl II): II - 450

    Google Scholar 

  45. Koch Weser J (1964) Myocardial actions of angiotensin II. Circ Res 14: 337–344

    Article  PubMed  CAS  Google Scholar 

  46. Koch-Weser J (1965) Nature of the inotropic action of angiotensin on ventricular myocardium. Circ Res 16: 230–237

    Article  PubMed  CAS  Google Scholar 

  47. Komuro I, Kurabayashi M, Takaku F, Yazaki Y (1988) Expression of cellular oncogenes in the myocardium during the developmental state and pressure-overloaded hypertrophy of the rat heart. Circ Res 62: 1075–1079

    Article  PubMed  CAS  Google Scholar 

  48. Kubo SH, Clark M, Laragh JH, Borer JH, Cody RI (1987) Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. Am J Cardiol 60: 1322–1328

    Article  PubMed  CAS  Google Scholar 

  49. Lindpaintner K, Jin M, Wilhelm MJ, Suzuki F, Linz W, Schoelkens BA, Ganten D (1988) Intracardiac generation of angiotensin and its physiologic role. Circulation 77 (suppl 1): 1–18

    Article  Google Scholar 

  50. Linz W, Scholkens BA, Ganten D (1989) Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Ex-per Hypertens All(7): 1325–1350

    Google Scholar 

  51. Michel JB, Cattion AL, Salzmann JL, de Lourdes Cerol M, Phillipe M, Camilleri JP, Coruol P (1988) Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 62: 641–650

    Article  PubMed  CAS  Google Scholar 

  52. Muller J, Lund EG, Hofstetter L, Brunner DB, Haldy P (1982) Stimulation of aldosterone biosynthesis by sodium sequestration: role of angiotensin II. Am J Physiol 243: E450 — E457

    PubMed  CAS  Google Scholar 

  53. Naftilan AJ, Pratt RE, Dzau VJ (1989) Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83: 1419–1424

    Article  PubMed  CAS  Google Scholar 

  54. Naftilan AJ, Pratt RE, Eldridge CS, Lin HL, Dzau VJ (1989) Angiotensin II c-fos expression in smooth muscle via transcriptional control. Hypertension 13: 706–711

    Article  PubMed  CAS  Google Scholar 

  55. Nakashima Y, Fouad FM, Tarazi RC (1984) Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 53: 1044–1049

    Article  PubMed  CAS  Google Scholar 

  56. Okamura T, Myazcki M, Inagemi T, Toda N (1986) Vascular renin-angiotensin system in two-kidney, one-clip hypertensive rats. Hypertension 8: 560–565

    Article  PubMed  CAS  Google Scholar 

  57. Oliver JA, Sciacca RR (1984) Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 74: 1247–1251

    Article  PubMed  CAS  Google Scholar 

  58. Oren S, Messerli FH, Grossman E, Garavaglia GE, Frolich ED (1991) Immediate and short-term effects of fosinopril, a new angiotensin converting enzyme inhibitor, in patients with essential hypertension. J Am Coll Cardiol 17: 1183–1187

    Article  PubMed  CAS  Google Scholar 

  59. Paul M, Schunkert H, Allen P, Dzau VJ (1990) Widespread distribution of angiotensin converting enzyme mRNA in human tissues. J Hypertens 8 (suppl 3): 36

    Google Scholar 

  60. Pfeffer JM, Pfeffer MA (1988) Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure. Am J Med 84: 37–44

    Article  PubMed  CAS  Google Scholar 

  61. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E (1991) Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 260 (Pt. 2): H1406–1414

    PubMed  CAS  Google Scholar 

  62. Pfeffer et al., The SAVE Investigators (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677

    Google Scholar 

  63. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186–188

    Article  PubMed  CAS  Google Scholar 

  64. Rakugi H, Jacob HJ, Ingelfmger JR, Krieger JE, Dzau VJ, Pratt RE (1990) Angiotensinogen gene expression in the myointima after vascular injury (abstract). Hypertension 16: 345

    Google Scholar 

  65. Rakugi H, Krieger J, Wang DS, Dzau VJ, Pratt RE (1991) Induction of angiotensin converting enzyme in neointima after balloon injury. Circulation 84 (suppl II): II - 113

    Google Scholar 

  66. Ragazzi E, Froldi G, Pandolfo L et al. (1989) Segmental impairment of endothelium-mediated relaxation in thoracic aortas from atherosclerotic rabbits. Comparison to cholesterol infiltration and energy metabolism. Artery 16: 327–345

    Google Scholar 

  67. Reidy MA, Fingerle J, Au YP, Majesky MW (1989) Correlation of mRNA expression of cellular mitogens and smooth muscle cell proliferation in arteries denuded of endothelium (Abstr). J Cell Biochem 13E (suppl 13): 194

    Google Scholar 

  68. Rosenthal JH, Pfieffer B, Mecheilor ML, Pschorr J, Jacob ICM, Dahlheim H (1984) Investigations of components of the renin-angiotensin system in rat vascular tissue. Hypertension 6: 383–390

    Article  PubMed  CAS  Google Scholar 

  69. Sakaguchi K, Chai SY, Jackson B, Johnston CI, Mendelsohn FA (1988) Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography. Hypertension 11: 230–238

    Google Scholar 

  70. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH (1990) Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest 86: 1913–1920

    Article  PubMed  CAS  Google Scholar 

  71. Skidgel RA, Defendini R, Erdos EG (1988) Angiotensin I converting enzyme and its role in neuropeptide metabolism. In: Turner AJ (ed) Neuropeptides and their peptidases; Ellis Horwood VCH, pp 165–188

    Google Scholar 

  72. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691

    Google Scholar 

  73. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B (1989) Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca++ mobilization and protein kinase C activation. J Biol Chem 264: 526–530

    Google Scholar 

  74. Urata H, Healey B, Stewart RW, Bumpus FM, Husain A (1989) Angiotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metab 69: 54–66

    Article  PubMed  CAS  Google Scholar 

  75. Urata H, Healey B, Stewart RW, Bumpus FM, Husain A (1990) Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 66: 883–890

    Article  PubMed  CAS  Google Scholar 

  76. Vlodaysky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M (1987) Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84: 2292–2296

    Google Scholar 

  77. Webb RC, Finta KM, Fisher M, Lee L, Pitt B (1992) Ramipril reverses impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. The FASEB Journal 6(No. 5: Part I ): Abstract 3022

    Google Scholar 

  78. Weber KT, Brilla CG, Janicki JS, Reddy HK (1991) Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulation hormones. Basic Res Cardiol 86 (suppl 3): 25–31

    PubMed  Google Scholar 

  79. Yamada H, Fabris B, Allen AM, Jackson B, Johnson CI, Mendelsohn FAO (1991) Localisation of angiotensin converting enzyme in the rat heart. Circ Res 68: 141–149

    Article  PubMed  CAS  Google Scholar 

  80. Xiang J, Linz W, Becker H, Ganten D, Lang RE, Schoelkens B, Unger T (1984) Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated rat heart. Eur J Pharmacol 113: 215–223

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California, USA

    Victor J. Dzau M.D. (Professor of Medicine, Chief)

Authors
  1. Victor J. Dzau M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Deutschland

    H. Grobecker

  2. Abt. Pathophysiologie Zentrum Innere Medizin, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland

    Gerd Heusch

  3. Abt. für Kardiologie, Pneumologie, Med. Klinik und Poliklinik B der Heinrich-Heine-Universität, Moorenstraße 5, 40225, Düsseldorf, Deutschland

    B. E. Strauer

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dzau, V.J. (1993). Lokale Expression und pathophysiologische Rolle von Renin-Angiotensin im Gefäßsystem und im Herzen. In: Grobecker, H., Heusch, G., Strauer, B.E. (eds) Angiotensin und Herz. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-11145-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-11145-1_1

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-11146-8

  • Online ISBN: 978-3-662-11145-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation